Funder
National Institutes of Health
VA Merit
Leroy Schecter Foundation
Bader Philanthropies
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Reference38 articles.
1. Arrieta-Cruz I, Gutierrez-Juarez R (2016) The role of insulin resistance and glucose metabolism dysregulation in the development of Alzheimer s disease. Rev Investig Clin 68(2):53–58
2. Artola A, Kamal A, Ramakers GM, Gardoni F, Di Luca M, Biessels GJ, Cattabeni F, Gispen WH (2002) Synaptic plasticity in the diabetic brain: advanced aging? Prog Brain Res 138:305–314
3. Bedse G, Di Domenico F, Serviddio G, Cassano T (2015) Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front Neurosci 9:204
4. Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM, Purohit DP, Lesser G, Grossman HT, Haroutunian V (2008) Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology. Neurology 71(10):750–757
5. Bond A (2006) Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus. Baylor Univ Med Cent Proc 19(3):281–284
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献